Navigation section

somatulin

  1. Cipla gets USFDA approval for pancreatic disease injection, shares surge

    Cipla gets USFDA approval for pancreatic disease injection, shares surge

    Mumbai (Maharashtra) [India], Mumbai-headquartered pharma major Cipla's US subsidiary has received final approval from the United States Food and Drug Administration (USFDA) for its Lanreotide Injection 120 mg/0.5 mL, 90 mg/0.3 mL and 60 Have done. mg/0. ML Injection, pre-filled and...
    • NewsBot
    • Article
    • approval cent cipla's company depot generic injection lanreotide last pharma price products rose somatulin version
    • Category: Business & Economy
  2. Cipla gets final USFDA approval for Lanreotide injection to treat tumors

    Cipla gets final USFDA approval for Lanreotide injection to treat tumors

    Acromegaly is a hormonal disorder, while GEP-NET is a rare type of tumor that can form in the pancreas or other parts of the gastrointestinal tract, including the stomach, small intestine, colon, rectum, and appendix.The company said it has received final approval for lanreotide injection in...
    • NewsBot
    • Article
    • 1 min read
    • acromegaly approval depot form gep-net hormonal injection lanreotide mg/0.3 mg/0.5 pancreas rare somatulin tumor type
    • Category: Technology & Innovation
  3. Cipla gets USFDA nod to market Lanreotide injection

    Cipla gets USFDA nod to market Lanreotide injection

    New Delhi: Drug major Cipla on Wednesday said it has received approval from the US health regulator to market a generic drug used to treat acromegaly and other conditions.The company has received final approval from the US Food and Drug Administration (USFDA) to market Lanreotide Injection in...
    • NewsBot
    • Article
    • 1 min read
    • acromegaly approval cipla depot drug drugmaker generic health injection lanreotide major market received somatulin wednesday
    • Category: Business & Economy
Back
Top